Skip header and navigation

31 records – page 1 of 2.

How to do a twin bag exchange

https://libcat.nshealth.ca/en/permalink/chpams34482
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0633
Available Online
View Pamphlet
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Subjects (LCSH)
Peritoneal dialysis
Specialty
Nephrology
Abstract
This pamphlet explains how to do your own peritoneal dialysis at home. It also explains how to deal with drain, fill, and mechanical problems. The Simplified Chinese version of this pamphlet 2214, is also available. The Russian version of this pamphlet 2379, is also available. The Vietnamese version of this pamphlet 2390, is also available.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0633
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis patients

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1445
Available Online
View Pamphlet
People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
People with kidney disease have a higher chance of having high potassium levels. High potassium levels may lead to an irregular heartbeat or cause problems with muscles and nerves. Kayexalate® is a drug that treats high potassium levels. This pamphlet explains how to take Kayexlate®, side effects, and how to store this medication.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Lanthanum (Fosrenol) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1466
Available Online
View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Lanthanum
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
Notes
Previous title: Fosrenol (Lanthanum) and hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1466
Less detail

Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1465
Available Online
View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Cinacalcet
Renal Insufficiency, Chronic - drug therapy
Hyperparathyroidism, Secondary - drug therapy
Subjects (LCSH)
Chronic renal failure
Hyperparathyroidism
Kidneys--Diseases--Treatment
Abstract
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
Notes
Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
Responsibility
Prepared by: Renal Program
Pamphlet Number
1465
Less detail

Sevelamer (Renagel) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1464
Available Online
View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Sevelamer
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Chronic renal failure
Kidneys--Diseases--Treatment
Abstract
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
Notes
Previous title: Renagel (Sevelamer) and Hemodialysis
Responsibility
Prepared by: Renal Program
Pamphlet Number
1464
Less detail

Oral irons and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1469
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Oral irons and CKD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Renal Insufficiency, Chronic - drug therapy
Anemia, Iron-Deficiency - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Iron deficiency anemia
Renal pharmacology
Abstract
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1469
Less detail

Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1493
Available Online
View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal insufficiency, chronic - complications
Anemia - drug therapy
Subjects (LCSH)
Chronic renal failure--Complications
Renal anemia
Abstract
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1493
Less detail

Injectable iron and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1495
Available Online
View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Iron - therapeutic use
Kidney Diseases
Anemia, Iron-Deficiency
Subjects (LCSH)
Hemodialysis
Chronic renal failure--Complications
Iron deficiency anemia
Abstract
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
Notes
Previous title: Injectable iron sucrose and chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1495
Less detail

Tums (calcium carbonate) and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1514
Available Online
View Pamphlet
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Calcium Carbonate - therapeutic use
Kidney Diseases - drug therapy
Subjects (LCSH)
Calcium carbonate
Kidneys--Diseases
Specialty
Nephrology
Abstract
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
Notes
Tums (calcium carbonate) and kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1514
Less detail
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0397
Available Online
View Pamphlet
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Fistula - radiography
Balloon Occlusion
Radiography, Interventional - methods
Subjects (LCSH)
Fistula
Therapeutic embolization
Specialty
Nephrology
Abstract
A fistuloplasty is a non-surgical procedure used to open blocked or narrowed blood vessels in your fistula. The blood vessel is stretched with a special balloon. The pamphlet outlines who will do your procedure, where it is done, how long you will be at the hospital, how to get ready, and how the procedure is done. What happens after, risks, and a list of symptoms to watch for are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0397
Less detail

Tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35616
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1032
Available Online
View Pamphlet
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Hemodialysis
Catheters
Specialty
Nephrology
Abstract
A tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialysis treatment. This pamphlet explains the procedure for having a tunneled hemodialysis catheter inserted. Topics include: why the catheter is used, how long it will be in place, where the procedure is done, how long you will be at the hospital, how to get ready, and how the catheter is inserted. Instructions for after your procedure and care at home are provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1032
Less detail

Non-tunneled hemodialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams35618
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1093
Available Online
View Pamphlet
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Vascular Access Devices
Subjects (LCSH)
Catheters
Hemodialysis
Specialty
Nephrology
Abstract
A non-tunneled hemodialysis catheter is a special tube made of plastic. It is used for hemodialyis treatment. This pamphlet explains the procedure for having a non-tunneled hemodialysis cathether inserted. Topics include: why the catheter is used, how long it can stay in place, how it is inserted, what will happen after the procedure, and how to care for your catheter at home. The pamphlet also explains what to do if the catheter falls out.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1093
Less detail

Care of your arteriovenous fistula

https://libcat.nshealth.ca/en/permalink/chpams35622
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0651
Available Online
View Pamphlet
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Central Venous Catheters
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Specialty
Nephrology
Abstract
An arteriovenous (AV) fistula gives access to your bloodstream for hemodialysis. It is made by joining an artery and a vein during surgery. This pamphlet explains when your fistula will be ready to use, what to expect after your surgery, how to care for your incision (cut), and how to exercise your fistula arm before and after surgery. It also includes information about what to do if you have bleeding at your fistula site, and a list of symptoms that need medical attention right away.
Responsibility
Prepared by: Renal Program
Pamphlet Number
0651
Less detail

Over-the-counter medications and chronic kidney disease (CKD)

https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1636
Available Online
View Pamphlet
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Nonprescription Drugs
Renal Insufficiency, Chronic - drug therapy
Subjects (LCSH)
Drugs, Nonprescription
Chronic renal failure
Abstract
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why you should not take any herbal or natural health products is included.
Notes
Previous title: Over-the-counter medications & chronic kidney disease
Responsibility
Prepared by: Renal Program
Pamphlet Number
1636
Less detail

Dalteparin (Fragmin) to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35807
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1760
Available Online
View Pamphlet
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Dalteparin
Renal Dialysis
Subjects (LCSH)
Hemodialysis
Blood--coagulation
Specialty
Nephrology
Abstract
Dalteparin is a medication that is part of a group of drugs called blood thinners. Fragmin® is the brand name of dalteparin. During hemodialysis your blood passes through the dialysis blood lines and a dialyzer (artificial kidney), which can cause clots to form. Dalteparin stops clots from forming. This pamphlet explains how to take dalteparin, possible side effects, and symptoms that you should mention to your nurse.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1760
Less detail

Prevnar 13 (pneumococcal conjugate vaccine) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36443
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1889
Available Online
View Pamphlet
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Str…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Heptavalent Pneumococcal Conjugate Vaccine
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Prevnar® 13 is a vaccine that protects against infections caused by the 13 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Prevnar® 13 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1889
Less detail

Pneumovax 23 (pneumococcal vaccine polyvalent) and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36445
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1890
Available Online
View Pamphlet
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Pneumococcal Vaccines
Streptococcus pneumoniae
Kidney Diseases
Subjects (LCSH)
Pneumococcal vaccine
Streptococcus pneumoniae
Kidneys--Diseases
Specialty
Nephrology
Abstract
Pneumovax® 23 is a vaccine that protects against infections caused by the 23 most common types of Streptococcus pneumoniae bacteria. Infections commonly caused by Streptococcus pneumoniae include pneumonia (an infection in the lungs, also called a chest infection), meningitis (an infection of the lining around the brain), bacteremia (an infection of the blood and organs), sinusitis (a sinus infection), and otitis media (a middle ear infection). This pamphlet explains what Pneumovax® 23 is, what Streptococcus pneumoniae is, why you need to get vaccinated, the possible side effects of the vaccine, who should not get the vaccine, and when you should get it.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1890
Less detail

Hepatitis B vaccine and kidney disease

https://libcat.nshealth.ca/en/permalink/chpams36604
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1425
Available Online
View Pamphlet
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Hepatitis B - prevention & control
Kidney Diseases
Subjects (LCSH)
Hepatitis B vaccine
Kidneys--Diseases
Specialty
Nephrology
Abstract
The liver is an organ in your body that helps to break down and digest the food you eat, cleans your blood, and fights infection. Hepatitis B is a virus that attacks the liver. “Hepatitis” means swelling of the liver. Hepatitis B can cause serious liver problems, including liver damage, liver failure, and liver cancer. People with kidney disease who may need dialysis or a kidney transplant in the future, have a higher chance of getting Hepatitis B. The best way to prevent Hepatitis B is to get vaccinated. This pamphlet explains what the hepatitis B vaccine is, possible side effects, and who should not get the vaccine.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1425
Less detail

Care of your peritoneal dialysis catheter

https://libcat.nshealth.ca/en/permalink/chpams36677
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0352
Available Online
View Pamphlet
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Kidney Diseases - surgery
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Specialty
Nephrology
Hematology
Abstract
This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given. The French version of this pamphlet 2098, "Prendre soin de votre cathéter de dialyse péritonéale", is also available.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
0352
Less detail

Prendre soin de votre cathéter de dialyse péritonéale

https://libcat.nshealth.ca/en/permalink/chpams36721
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
2098
Available Online
View Pamphlet
La brochure porte sur la façon de protéger votre cathéter de dialyse péritonéale. On y traite des soins de l’incision (coupure) ou du point d'émergence cutané (point de sortie) après l’opération et du maintien de la régularité intestinale. On vous indique aussi quand appeler l’infirmière de l’Ordre de Victoria du Canada (VON) ou des soins à domicile. ; This pamphlet is a French translation of "Care of Your Peritoneal Dialysis Catheter" pamphlet 0352. This pamphlet reviews how to protect your pe…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Care of your peritoneal dialysis catheter
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
French
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Peritoneal Dialysis
Kidney Diseases - surgery
Subjects (LCSH)
Peritoneal access
Peritoneal dialysis
Specialty
Nephrology
Hematology
Abstract
La brochure porte sur la façon de protéger votre cathéter de dialyse péritonéale. On y traite des soins de l’incision (coupure) ou du point d'émergence cutané (point de sortie) après l’opération et du maintien de la régularité intestinale. On vous indique aussi quand appeler l’infirmière de l’Ordre de Victoria du Canada (VON) ou des soins à domicile.
This pamphlet is a French translation of "Care of Your Peritoneal Dialysis Catheter" pamphlet 0352. This pamphlet reviews how to protect your peritoneal dialysis catheter. Information includes how to care for your incision (cut) or exit site after surgery and keeping your bowels regular. Information about when to call your VON or home care nurse is also given.
Responsibility
Prepared by: NSHA Renal Program
Pamphlet Number
2098
Less detail

31 records – page 1 of 2.